Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer.

Fong Lien Audrey KwongCaroline KristunasClare DavenportJon DeeksSue MallettRidhi AgarwalSean KehoeDirk TimmermanTom BourneHilary StobartRichard NealUsha MenonAlex Gentry-MaharajJames BrentonNitzan RosenfeldLauren SturdyRyan OttridgeSudha S Sundarnull null

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)

Our results demonstrate that one in four women identified with high grade serous ovarian cancer through the fast-track pathway following symptom-triggered testing was diagnosed with early-stage disease. Symptom-triggered testing may help identify women with a low disease burden, potentially contributing to high complete cytoreduction rates.

Keyphrases

early stage
high grade
low grade
sentinel lymph node
patient reported
polycystic ovary syndrome
squamous cell carcinoma
adipose tissue
locally advanced
pregnancy outcomes
risk factors